Ligand Pharmaceuticals Incorporated (LGND) Q4 2025 Earnings Call Transcript

February 26, 2026 05:47:46 pm

Source: SeekingAlpha

2026-02-26 17:47:46 ET

Ligand Pharmaceuticals Incorporated (LGND) Q4 2025 Earnings Call February 26, 2026 8:30 AM EST...

For further details see:

Ligand Pharms Glucagon

0.96% G/L:

$0.0021 Last:

100 Volume:

$0.00208 Open:

Market Cap $3,679,103,920

Float 18,304,000

Insiders Ownership N/A

Institutions 151

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Jupiter